found that the CCL15/CCR1 axis forms a complex tumor‐promoting inflammatory microenvironment in human HCC and that blocking the CCL15/CCR1 axis in HCC may be an effective method for cancer treatment [14]. This evidence concerns the gene CCR1 and hepatocellular carcinoma.